サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1513327

人工心臓弁市場、製品別：世界の機会分析と産業予測、2024年～2035年

Prosthetic Heart Valve Market By Product (Mechanical Heart Valve, Tissue Heart Valve, Transcatheter Heart Valve): Global Opportunity Analysis and Industry Forecast, 2024-2035

出版日
ページ情報
英文 212 Pages
納期
2～3営業日
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
人工心臓弁市場、製品別：世界の機会分析と産業予測、2024年～2035年
出版日: 2024年04月01日
発行: Allied Market Research
ページ情報: 英文 212 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要
人工心臓弁市場は2023年に86億米ドルと評価され、2024年から2035年までのCAGRは11.1％を記録し、2035年には303億米ドルに達すると予測されています。人工心臓弁は、損傷したり病気になったりした心臓弁を人工的に置き換える役割を果たすもので、心臓の部屋への血液の出入りを調節する重要な部品です。これらの弁の機能不全は、息切れ、疲労、胸痛、さらには心不全など、さまざまな心血管系の問題を引き起こす可能性があります。健康な心臓弁の機能を模倣して設計された人工心臓弁は、全身への適切な血液循環を促進します。人工心臓弁の主な種類には、機械式心臓弁、組織式心臓弁、経カテーテル心臓弁があります。
Prosthetic Heart Valve Market-IMG1
人工心臓弁市場の成長は、主に心臓弁疾患の有病率の増加、心臓弁の技術的進歩、低侵襲処置の需要の増加によってもたらされます。例えば、米国心臓病学会（American College of Cardiology 2021）によると、米国では毎年500万人以上が心臓弁膜症（VHD）と診断されており、心臓弁膜症（VHD）の有病率の上昇が市場成長の原動力となっています。加えて、低侵襲処置に対する需要の急増が、経カテーテル心臓弁置換術の採用を後押ししています。低侵襲で回復も早いこのアプローチは、従来の開心術よりもますます支持されるようになり、市場成長を牽引しています。さらに、世界中で心臓弁手術の件数が増加していることも、人工心臓弁市場の成長を後押しすると予想されています。例えば、国立医学図書館が2022年に発表した論文によると、世界中で年間20万件の心臓弁置換手術が行われており、2050年には85万件に増加すると予想されています。したがって、心臓弁手術件数の増加は人工心臓弁の需要をもたらし、市場の成長を促進します。人口の高齢化は世界の現象であり、この人口動態の変化は予測期間中も人工心臓弁の需要を促進すると予想されます。このような心臓疾患の増加は、大動脈弁狭窄症、僧帽弁狭窄症、僧帽弁閉鎖不全症を含む様々な心臓弁疾患の治療に使用される人工心臓弁の需要を促進します。心臓疾患の有病率の急増と人口の高齢化に加えて、人工心臓弁市場は患者の意識の高まりによって牽引されています。患者は自分の健康状態や利用可能な治療法について知識を深めており、これが心臓弁膜症に対する安全で効果的な治療法として人工心臓弁の需要増につながっています。さらに、心臓弁膜症に関する政府の取り組みや意識の高まりが市場の成長を促進しています。世界中の政府が心臓弁膜症の新しい治療法の研究開発に投資しており、それが先進的な人工心臓弁装置の開発につながっています。加えて、心臓弁膜症に関連する症状や危険因子に対する認識が高まったことで、心臓弁膜症の治療を求める人が増え、これが市場の成長をさらに後押ししています。人工心臓弁市場は、製品と地域によって区分されます。製品別では、機械式心臓弁、組織式心臓弁、経カテーテル心臓弁に分類されます。組織弁セグメントはさらに、ステント付き組織弁とステントレス組織弁に分類されます。地域別では、市場は北米（米国、カナダ、メキシコ）、欧州（ドイツ、フランス、英国、イタリア、スペイン、その他欧州地域）、アジア太平洋地域（日本、中国、オーストラリア、インド、韓国、その他アジア太平洋地域）、南米地域（ブラジル、サウジアラビア、アフリカ、その他南米地域）で分析されます。世界の人工心臓弁市場で事業を展開する主な主要企業は、Abbott Laboratories、Boston Scientific Corporation、ShockWave Medical, Inc.、Edward Lifesciences Corporation、Colibri Heart Valve、Medtronic plc、Meril Life Sciences Pvt. Ltd.、Labcor Laboratorios Ltda、Artivion, Inc.、JenaValve Technology, Inc.です。市場で事業を展開する主要企業は、製品ポートフォリオを拡大するための主要戦略として、契約、製品上市、製品承認、リブランディングを採用している

利害関係者にとっての主なメリット

  • 本レポートは、2023年から2035年までの人工心臓弁市場分析の市場セグメント、現在の動向、推定・動向、力学の定量分析を提供し、一般的な人工心臓弁市場の機会を特定します。
  • 市場促進要因、市場抑制要因、市場機会に関連する情報とともに市場調査を提供します。
  • ポーターのファイブフォース分析では、利害関係者が利益重視のビジネス決定を行い、サプライヤーとバイヤーのネットワークを強化できるように、バイヤーとサプライヤーの潜在力を強調します。
  • 人工心臓弁市場のセグメンテーションの詳細な分析は、市場機会を決定するのに役立ちます。
  • 各地域の主要国は、世界市場への収益貢献度に応じてマッピングされています。
  • 市場プレイヤーのポジショニングは、ベンチマーキングを容易にし、市場プレイヤーの現在のポジションの明確な理解を提供します。
  • 本レポートには、地域および世界の人工心臓弁市場動向、主要企業、市場セグメント、応用分野、市場成長戦略の分析が含まれています。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 市場概要

  • 市場の定義と範囲
  • 主な調査結果
    • 影響要因
    • 主な投資機会
  • ポーターのファイブフォース分析
  • 市場力学
    • 促進要因
    • 抑制要因
    • 機会

第4章 人工心臓弁市場：製品別

  • 概要
  • 機械式心臓弁
  • 組織心臓弁
    • 組織心臓弁人工心臓弁市場、タイプ別
  • 経カテーテル心臓弁

第5章 人工心臓弁市場：地域別

  • 概要
  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • その他
  • アジア太平洋
    • 日本
    • 中国
    • インド
    • オーストラリア
    • 韓国
    • その他
  • ラテンアメリカ・中東・アフリカ
    • ブラジル
    • サウジアラビア
    • 南アフリカ
    • その他

第6章 競争情勢

  • イントロダクション
  • 主要成功戦略
  • 主要10社の製品マッピング
  • 競合ダッシュボード
  • 競合ヒートマップ
  • 主要企業のポジショニング、2023年

第7章 企業プロファイル

  • Meril Life Sciences Pvt. Ltd.
  • Abbott Laboratories
  • Labcor Laboratorios Ltda
  • Artivion, Inc.
  • Boston Scientific Corporation
  • LivaNova PLC
  • Edwards Lifesciences Corporation
  • ShockWave Medical, Inc.
  • Medtronic plc
  • JenaValve Technology, Inc.
図表

LIST OF TABLES

  • TABLE 01. GLOBAL PROSTHETIC HEART VALVE MARKET, BY PRODUCT, 2023-2035 ($MILLION)
  • TABLE 02. PROSTHETIC HEART VALVE MARKET FOR MECHANICAL HEART VALVE, BY REGION, 2023-2035 ($MILLION)
  • TABLE 03. PROSTHETIC HEART VALVE MARKET FOR TISSUE HEART VALVE, BY REGION, 2023-2035 ($MILLION)
  • TABLE 04. GLOBAL TISSUE HEART VALVE PROSTHETIC HEART VALVE MARKET, BY TYPE, 2023-2035 ($MILLION)
  • TABLE 05. PROSTHETIC HEART VALVE MARKET FOR TRANSCATHETER HEART VALVE, BY REGION, 2023-2035 ($MILLION)
  • TABLE 06. PROSTHETIC HEART VALVE MARKET, BY REGION, 2023-2035 ($MILLION)
  • TABLE 07. NORTH AMERICA PROSTHETIC HEART VALVE MARKET, BY PRODUCT, 2023-2035 ($MILLION)
  • TABLE 08. NORTH AMERICA PROSTHETIC HEART VALVE MARKET, BY COUNTRY, 2023-2035 ($MILLION)
  • TABLE 09. U.S. PROSTHETIC HEART VALVE MARKET, BY PRODUCT, 2023-2035 ($MILLION)
  • TABLE 10. CANADA PROSTHETIC HEART VALVE MARKET, BY PRODUCT, 2023-2035 ($MILLION)
  • TABLE 11. MEXICO PROSTHETIC HEART VALVE MARKET, BY PRODUCT, 2023-2035 ($MILLION)
  • TABLE 12. EUROPE PROSTHETIC HEART VALVE MARKET, BY PRODUCT, 2023-2035 ($MILLION)
  • TABLE 13. EUROPE PROSTHETIC HEART VALVE MARKET, BY COUNTRY, 2023-2035 ($MILLION)
  • TABLE 14. GERMANY PROSTHETIC HEART VALVE MARKET, BY PRODUCT, 2023-2035 ($MILLION)
  • TABLE 15. FRANCE PROSTHETIC HEART VALVE MARKET, BY PRODUCT, 2023-2035 ($MILLION)
  • TABLE 16. UK PROSTHETIC HEART VALVE MARKET, BY PRODUCT, 2023-2035 ($MILLION)
  • TABLE 17. ITALY PROSTHETIC HEART VALVE MARKET, BY PRODUCT, 2023-2035 ($MILLION)
  • TABLE 18. SPAIN PROSTHETIC HEART VALVE MARKET, BY PRODUCT, 2023-2035 ($MILLION)
  • TABLE 19. REST OF EUROPE PROSTHETIC HEART VALVE MARKET, BY PRODUCT, 2023-2035 ($MILLION)
  • TABLE 20. ASIA-PACIFIC PROSTHETIC HEART VALVE MARKET, BY PRODUCT, 2023-2035 ($MILLION)
  • TABLE 21. ASIA-PACIFIC PROSTHETIC HEART VALVE MARKET, BY COUNTRY, 2023-2035 ($MILLION)
  • TABLE 22. JAPAN PROSTHETIC HEART VALVE MARKET, BY PRODUCT, 2023-2035 ($MILLION)
  • TABLE 23. CHINA PROSTHETIC HEART VALVE MARKET, BY PRODUCT, 2023-2035 ($MILLION)
  • TABLE 24. INDIA PROSTHETIC HEART VALVE MARKET, BY PRODUCT, 2023-2035 ($MILLION)
  • TABLE 25. AUSTRALIA PROSTHETIC HEART VALVE MARKET, BY PRODUCT, 2023-2035 ($MILLION)
  • TABLE 26. SOUTH KOREA PROSTHETIC HEART VALVE MARKET, BY PRODUCT, 2023-2035 ($MILLION)
  • TABLE 27. REST OF ASIA-PACIFIC PROSTHETIC HEART VALVE MARKET, BY PRODUCT, 2023-2035 ($MILLION)
  • TABLE 28. LAMEA PROSTHETIC HEART VALVE MARKET, BY PRODUCT, 2023-2035 ($MILLION)
  • TABLE 29. LAMEA PROSTHETIC HEART VALVE MARKET, BY COUNTRY, 2023-2035 ($MILLION)
  • TABLE 30. BRAZIL PROSTHETIC HEART VALVE MARKET, BY PRODUCT, 2023-2035 ($MILLION)
  • TABLE 31. SAUDI ARABIA PROSTHETIC HEART VALVE MARKET, BY PRODUCT, 2023-2035 ($MILLION)
  • TABLE 32. SOUTH AFRICA PROSTHETIC HEART VALVE MARKET, BY PRODUCT, 2023-2035 ($MILLION)
  • TABLE 33. REST OF LAMEA PROSTHETIC HEART VALVE MARKET, BY PRODUCT, 2023-2035 ($MILLION)
  • TABLE 34. MERIL LIFE SCIENCES PVT. LTD.: KEY EXECUTIVES
  • TABLE 35. MERIL LIFE SCIENCES PVT. LTD.: COMPANY SNAPSHOT
  • TABLE 36. MERIL LIFE SCIENCES PVT. LTD.: PRODUCT SEGMENTS
  • TABLE 37. MERIL LIFE SCIENCES PVT. LTD.: SERVICE SEGMENTS
  • TABLE 38. MERIL LIFE SCIENCES PVT. LTD.: PRODUCT PORTFOLIO
  • TABLE 39. MERIL LIFE SCIENCES PVT. LTD.: KEY STRATEGIES
  • TABLE 40. ABBOTT LABORATORIES: KEY EXECUTIVES
  • TABLE 41. ABBOTT LABORATORIES: COMPANY SNAPSHOT
  • TABLE 42. ABBOTT LABORATORIES: PRODUCT SEGMENTS
  • TABLE 43. ABBOTT LABORATORIES: SERVICE SEGMENTS
  • TABLE 44. ABBOTT LABORATORIES: PRODUCT PORTFOLIO
  • TABLE 45. ABBOTT LABORATORIES: KEY STRATEGIES
  • TABLE 46. LABCOR LABORATORIOS LTDA: KEY EXECUTIVES
  • TABLE 47. LABCOR LABORATORIOS LTDA: COMPANY SNAPSHOT
  • TABLE 48. LABCOR LABORATORIOS LTDA: PRODUCT SEGMENTS
  • TABLE 49. LABCOR LABORATORIOS LTDA: SERVICE SEGMENTS
  • TABLE 50. LABCOR LABORATORIOS LTDA: PRODUCT PORTFOLIO
  • TABLE 51. LABCOR LABORATORIOS LTDA: KEY STRATEGIES
  • TABLE 52. ARTIVION, INC.: KEY EXECUTIVES
  • TABLE 53. ARTIVION, INC.: COMPANY SNAPSHOT
  • TABLE 54. ARTIVION, INC.: PRODUCT SEGMENTS
  • TABLE 55. ARTIVION, INC.: SERVICE SEGMENTS
  • TABLE 56. ARTIVION, INC.: PRODUCT PORTFOLIO
  • TABLE 57. ARTIVION, INC.: KEY STRATEGIES
  • TABLE 58. BOSTON SCIENTIFIC CORPORATION: KEY EXECUTIVES
  • TABLE 59. BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT
  • TABLE 60. BOSTON SCIENTIFIC CORPORATION: PRODUCT SEGMENTS
  • TABLE 61. BOSTON SCIENTIFIC CORPORATION: SERVICE SEGMENTS
  • TABLE 62. BOSTON SCIENTIFIC CORPORATION: PRODUCT PORTFOLIO
  • TABLE 63. BOSTON SCIENTIFIC CORPORATION: KEY STRATEGIES
  • TABLE 64. LIVANOVA PLC: KEY EXECUTIVES
  • TABLE 65. LIVANOVA PLC: COMPANY SNAPSHOT
  • TABLE 66. LIVANOVA PLC: PRODUCT SEGMENTS
  • TABLE 67. LIVANOVA PLC: SERVICE SEGMENTS
  • TABLE 68. LIVANOVA PLC: PRODUCT PORTFOLIO
  • TABLE 69. LIVANOVA PLC: KEY STRATEGIES
  • TABLE 70. EDWARDS LIFESCIENCES CORPORATION: KEY EXECUTIVES
  • TABLE 71. EDWARDS LIFESCIENCES CORPORATION: COMPANY SNAPSHOT
  • TABLE 72. EDWARDS LIFESCIENCES CORPORATION: PRODUCT SEGMENTS
  • TABLE 73. EDWARDS LIFESCIENCES CORPORATION: SERVICE SEGMENTS
  • TABLE 74. EDWARDS LIFESCIENCES CORPORATION: PRODUCT PORTFOLIO
  • TABLE 75. EDWARDS LIFESCIENCES CORPORATION: KEY STRATEGIES
  • TABLE 76. SHOCKWAVE MEDICAL, INC.: KEY EXECUTIVES
  • TABLE 77. SHOCKWAVE MEDICAL, INC.: COMPANY SNAPSHOT
  • TABLE 78. SHOCKWAVE MEDICAL, INC.: PRODUCT SEGMENTS
  • TABLE 79. SHOCKWAVE MEDICAL, INC.: SERVICE SEGMENTS
  • TABLE 80. SHOCKWAVE MEDICAL, INC.: PRODUCT PORTFOLIO
  • TABLE 81. SHOCKWAVE MEDICAL, INC.: KEY STRATEGIES
  • TABLE 82. MEDTRONIC PLC: KEY EXECUTIVES
  • TABLE 83. MEDTRONIC PLC: COMPANY SNAPSHOT
  • TABLE 84. MEDTRONIC PLC: PRODUCT SEGMENTS
  • TABLE 85. MEDTRONIC PLC: SERVICE SEGMENTS
  • TABLE 86. MEDTRONIC PLC: PRODUCT PORTFOLIO
  • TABLE 87. MEDTRONIC PLC: KEY STRATEGIES
  • TABLE 88. JENAVALVE TECHNOLOGY, INC.: KEY EXECUTIVES
  • TABLE 89. JENAVALVE TECHNOLOGY, INC.: COMPANY SNAPSHOT
  • TABLE 90. JENAVALVE TECHNOLOGY, INC.: PRODUCT SEGMENTS
  • TABLE 91. JENAVALVE TECHNOLOGY, INC.: SERVICE SEGMENTS
  • TABLE 92. JENAVALVE TECHNOLOGY, INC.: PRODUCT PORTFOLIO
  • TABLE 93. JENAVALVE TECHNOLOGY, INC.: KEY STRATEGIES

LIST OF FIGURES

  • FIGURE 01. PROSTHETIC HEART VALVE MARKET, 2023-2035
  • FIGURE 02. SEGMENTATION OF PROSTHETIC HEART VALVE MARKET,2023-2035
  • FIGURE 03. TOP IMPACTING FACTORS IN PROSTHETIC HEART VALVE MARKET
  • FIGURE 04. TOP INVESTMENT POCKETS IN PROSTHETIC HEART VALVE MARKET (2024-2035)
  • FIGURE 05. BARGAINING POWER OF SUPPLIERS
  • FIGURE 06. BARGAINING POWER OF BUYERS
  • FIGURE 07. THREAT OF SUBSTITUTION
  • FIGURE 08. THREAT OF SUBSTITUTION
  • FIGURE 09. COMPETITIVE RIVALRY
  • FIGURE 10. GLOBAL PROSTHETIC HEART VALVE MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
  • FIGURE 11. PROSTHETIC HEART VALVE MARKET, BY PRODUCT, 2023 AND 2035(%)
  • FIGURE 12. COMPARATIVE SHARE ANALYSIS OF PROSTHETIC HEART VALVE MARKET FOR MECHANICAL HEART VALVE, BY COUNTRY 2023 AND 2035(%)
  • FIGURE 13. COMPARATIVE SHARE ANALYSIS OF PROSTHETIC HEART VALVE MARKET FOR TISSUE HEART VALVE, BY COUNTRY 2023 AND 2035(%)
  • FIGURE 14. COMPARATIVE SHARE ANALYSIS OF PROSTHETIC HEART VALVE MARKET FOR TRANSCATHETER HEART VALVE, BY COUNTRY 2023 AND 2035(%)
  • FIGURE 15. PROSTHETIC HEART VALVE MARKET BY REGION, 2023 AND 2035(%)
  • FIGURE 16. U.S. PROSTHETIC HEART VALVE MARKET, 2023-2035 ($MILLION)
  • FIGURE 17. CANADA PROSTHETIC HEART VALVE MARKET, 2023-2035 ($MILLION)
  • FIGURE 18. MEXICO PROSTHETIC HEART VALVE MARKET, 2023-2035 ($MILLION)
  • FIGURE 19. GERMANY PROSTHETIC HEART VALVE MARKET, 2023-2035 ($MILLION)
  • FIGURE 20. FRANCE PROSTHETIC HEART VALVE MARKET, 2023-2035 ($MILLION)
  • FIGURE 21. UK PROSTHETIC HEART VALVE MARKET, 2023-2035 ($MILLION)
  • FIGURE 22. ITALY PROSTHETIC HEART VALVE MARKET, 2023-2035 ($MILLION)
  • FIGURE 23. SPAIN PROSTHETIC HEART VALVE MARKET, 2023-2035 ($MILLION)
  • FIGURE 24. REST OF EUROPE PROSTHETIC HEART VALVE MARKET, 2023-2035 ($MILLION)
  • FIGURE 25. JAPAN PROSTHETIC HEART VALVE MARKET, 2023-2035 ($MILLION)
  • FIGURE 26. CHINA PROSTHETIC HEART VALVE MARKET, 2023-2035 ($MILLION)
  • FIGURE 27. INDIA PROSTHETIC HEART VALVE MARKET, 2023-2035 ($MILLION)
  • FIGURE 28. AUSTRALIA PROSTHETIC HEART VALVE MARKET, 2023-2035 ($MILLION)
  • FIGURE 29. SOUTH KOREA PROSTHETIC HEART VALVE MARKET, 2023-2035 ($MILLION)
  • FIGURE 30. REST OF ASIA-PACIFIC PROSTHETIC HEART VALVE MARKET, 2023-2035 ($MILLION)
  • FIGURE 31. BRAZIL PROSTHETIC HEART VALVE MARKET, 2023-2035 ($MILLION)
  • FIGURE 32. SAUDI ARABIA PROSTHETIC HEART VALVE MARKET, 2023-2035 ($MILLION)
  • FIGURE 33. SOUTH AFRICA PROSTHETIC HEART VALVE MARKET, 2023-2035 ($MILLION)
  • FIGURE 34. REST OF LAMEA PROSTHETIC HEART VALVE MARKET, 2023-2035 ($MILLION)
  • FIGURE 35. TOP WINNING STRATEGIES, BY YEAR
  • FIGURE 36. TOP WINNING STRATEGIES, BY DEVELOPMENT
  • FIGURE 37. TOP WINNING STRATEGIES, BY COMPANY
  • FIGURE 38. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 39. COMPETITIVE DASHBOARD
  • FIGURE 40. COMPETITIVE HEATMAP: PROSTHETIC HEART VALVE MARKET
  • FIGURE 41. TOP PLAYER POSITIONING, 2023
目次
Product Code: A01846
The prosthetic heart valve market was valued at $8.6 billion in 2023 and is projected to reach $30.3 billion by 2035, registering a CAGR of 11.1% from 2024 to 2035. Prosthetic heart valves serve as synthetic replacements for damaged or diseased heart valves, crucial components that regulate blood flow in and out of the heart's chambers. Dysfunction in these valves can lead to a spectrum of cardiovascular issues, including shortness of breath, fatigue, chest pain, and even heart failure. Designed to mimic the functionality of healthy heart valves, prosthetic heart valves facilitate proper blood circulation throughout the body. The primary types of prosthetic heart valves are mechanical heart valves, tissue heart valves, and transcatheter heart valves.
Prosthetic Heart Valve Market - IMG1
The growth of the prosthetic heart valve market is primarily driven by increasing prevalence of heart valve diseases, technological advancements in heart valves, and increase in demand for minimally invasive procedures. For instance, according to American College of Cardiology 2021, more than 5 million people are diagnosed with valvular heart diseases (VHD) each year in the U.S. Thus, rise in prevalence of valvular heart diseases (VHD) drives the market growth. In addition, surge in demand for minimally invasive procedures, propelling the adoption of transcatheter heart valve replacement. This approach, highlighted for its reduced invasiveness and quicker recovery, has become increasingly favored over traditional open-heart surgery, driving market growth. Furthermore, a rise in the number of heart valve surgeries across the world is expected to boost the growth of the prosthetic heart valve market. For instance, an article published by National Library of Medicine in 2022, 200,000 heart valve replacement surgeries are performed annually worldwide, and is expected to increase to 8,50,000 by 2050, Thus, rise in number of heart valve surgeries results in demand for prosthetic heart valve and fuels the market growth. The aging of the population is a global phenomenon, and this demographic shift is expected to continue to drive demand for these prosthetic heart valve devices during the forecast period. This increase in cardiac disorders drives the demand for prosthetic heart valves, which are used to treat a range of heart valve diseases, including aortic stenosis, mitral stenosis, and mitral regurgitation. In addition to the surge in prevalence of cardiac disorders and the aging of the population, the prosthetic heart valve market is being driven by increased patient awareness. Patients have become more informed about their health and the available treatment options, and this is leading to increased demand for prosthetic heart valves as a safe and effective treatment option for heart valve diseases. Moreover, increased government initiatives and awareness regarding heart valve diseases foster the growth of the market. Governments around the world invest in R&D of new treatments for heart valve diseases, which has led to the development of advanced prosthetic heart valve devices. In addition, rise in awareness about the symptoms and risk factors associated with heart valve disease have led to more people seeking medical treatment for the condition, which has further driven the growth of the market. The prosthetic heart valve market is segmented on the basis of product and region. By product, the market is categorized into mechanical heart valve, tissue heart valve, and transcatheter heart valve. The tissue heart valve segment is further classified into stented tissue heart valve and stent less tissue heart valve. Region wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, and rest of LAMEA). Major key players that operate in the global prosthetic heart valve market are Abbott Laboratories, Boston Scientific Corporation, ShockWave Medical, Inc., Edward Lifesciences Corporation, Colibri Heart Valve, Medtronic plc, Meril Life Sciences Pvt. Ltd., Labcor Laboratorios Ltda, Artivion, Inc, and JenaValve Technology, Inc. The key players operating in the market have adopted agreement, product launch, product approval, and rebranding as their key strategies to expand their product portfolio

Key Benefits for Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the prosthetic heart valve market analysis from 2023 to 2035 to identify the prevailing prosthetic heart valve market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the prosthetic heart valve market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global prosthetic heart valve market trends, key players, market segments, application areas, and market growth strategies.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)
  • Regulatory Guidelines
  • Additional company profiles with specific to client's interest
  • Additional country or region analysis- market size and forecast
  • Expanded list for Company Profiles
  • Historic market data
  • Key player details (including location, contact details, supplier/vendor network etc. in excel format)

Key Market Segments

By Product

  • Tissue Heart Valve
    • Type
    • Stented Tissue Heart Valve
    • Stentless Tissue Heart Valve
  • Mechanical Heart Valve
  • Transcatheter Heart Valve

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA

Key Market Players:

    • Meril Life Sciences Pvt. Ltd.
    • Abbott Laboratories
    • Labcor Laboratorios Ltda
    • Artivion, Inc.
    • Boston Scientific Corporation
    • LivaNova PLC
    • Edwards Lifesciences Corporation
    • ShockWave Medical, Inc.
    • Medtronic plc
    • JenaValve Technology, Inc.

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report description
  • 1.2. Key market segments
  • 1.3. Key benefits to the stakeholders
  • 1.4. Research methodology
    • 1.4.1. Primary research
    • 1.4.2. Secondary research
    • 1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO perspective

CHAPTER 3: MARKET OVERVIEW

  • 3.1. Market definition and scope
  • 3.2. Key findings
    • 3.2.1. Top impacting factors
    • 3.2.2. Top investment pockets
  • 3.3. Porter's five forces analysis
  • 3.4. Market dynamics
    • 3.4.1. Drivers
    • 3.4.2. Restraints
    • 3.4.3. Opportunities

CHAPTER 4: PROSTHETIC HEART VALVE MARKET, BY PRODUCT

  • 4.1. Overview
    • 4.1.1. Market size and forecast
  • 4.2. Mechanical Heart Valve
    • 4.2.1. Key market trends, growth factors and opportunities
    • 4.2.2. Market size and forecast, by region
    • 4.2.3. Market share analysis by country
  • 4.3. Tissue Heart Valve
    • 4.3.1. Key market trends, growth factors and opportunities
    • 4.3.2. Market size and forecast, by region
    • 4.3.3. Market share analysis by country
    • 4.3.4. Tissue Heart Valve Prosthetic Heart Valve Market by Type
  • 4.4. Transcatheter Heart Valve
    • 4.4.1. Key market trends, growth factors and opportunities
    • 4.4.2. Market size and forecast, by region
    • 4.4.3. Market share analysis by country

CHAPTER 5: PROSTHETIC HEART VALVE MARKET, BY REGION

  • 5.1. Overview
    • 5.1.1. Market size and forecast By Region
  • 5.2. North America
    • 5.2.1. Key market trends, growth factors and opportunities
    • 5.2.2. Market size and forecast, by Product
    • 5.2.3. Market size and forecast, by country
      • 5.2.3.1. U.S.
      • 5.2.3.1.1. Market size and forecast, by Product
      • 5.2.3.2. Canada
      • 5.2.3.2.1. Market size and forecast, by Product
      • 5.2.3.3. Mexico
      • 5.2.3.3.1. Market size and forecast, by Product
  • 5.3. Europe
    • 5.3.1. Key market trends, growth factors and opportunities
    • 5.3.2. Market size and forecast, by Product
    • 5.3.3. Market size and forecast, by country
      • 5.3.3.1. Germany
      • 5.3.3.1.1. Market size and forecast, by Product
      • 5.3.3.2. France
      • 5.3.3.2.1. Market size and forecast, by Product
      • 5.3.3.3. UK
      • 5.3.3.3.1. Market size and forecast, by Product
      • 5.3.3.4. Italy
      • 5.3.3.4.1. Market size and forecast, by Product
      • 5.3.3.5. Spain
      • 5.3.3.5.1. Market size and forecast, by Product
      • 5.3.3.6. Rest of Europe
      • 5.3.3.6.1. Market size and forecast, by Product
  • 5.4. Asia-Pacific
    • 5.4.1. Key market trends, growth factors and opportunities
    • 5.4.2. Market size and forecast, by Product
    • 5.4.3. Market size and forecast, by country
      • 5.4.3.1. Japan
      • 5.4.3.1.1. Market size and forecast, by Product
      • 5.4.3.2. China
      • 5.4.3.2.1. Market size and forecast, by Product
      • 5.4.3.3. India
      • 5.4.3.3.1. Market size and forecast, by Product
      • 5.4.3.4. Australia
      • 5.4.3.4.1. Market size and forecast, by Product
      • 5.4.3.5. South Korea
      • 5.4.3.5.1. Market size and forecast, by Product
      • 5.4.3.6. Rest of Asia-Pacific
      • 5.4.3.6.1. Market size and forecast, by Product
  • 5.5. LAMEA
    • 5.5.1. Key market trends, growth factors and opportunities
    • 5.5.2. Market size and forecast, by Product
    • 5.5.3. Market size and forecast, by country
      • 5.5.3.1. Brazil
      • 5.5.3.1.1. Market size and forecast, by Product
      • 5.5.3.2. Saudi Arabia
      • 5.5.3.2.1. Market size and forecast, by Product
      • 5.5.3.3. South Africa
      • 5.5.3.3.1. Market size and forecast, by Product
      • 5.5.3.4. Rest of LAMEA
      • 5.5.3.4.1. Market size and forecast, by Product

CHAPTER 6: COMPETITIVE LANDSCAPE

  • 6.1. Introduction
  • 6.2. Top winning strategies
  • 6.3. Product mapping of top 10 player
  • 6.4. Competitive dashboard
  • 6.5. Competitive heatmap
  • 6.6. Top player positioning, 2023

CHAPTER 7: COMPANY PROFILES

  • 7.1. Meril Life Sciences Pvt. Ltd.
    • 7.1.1. Company overview
    • 7.1.2. Key executives
    • 7.1.3. Company snapshot
    • 7.1.4. Operating business segments
    • 7.1.5. Product portfolio
    • 7.1.6. Business performance
    • 7.1.7. Key strategic moves and developments
  • 7.2. Abbott Laboratories
    • 7.2.1. Company overview
    • 7.2.2. Key executives
    • 7.2.3. Company snapshot
    • 7.2.4. Operating business segments
    • 7.2.5. Product portfolio
    • 7.2.6. Business performance
    • 7.2.7. Key strategic moves and developments
  • 7.3. Labcor Laboratorios Ltda
    • 7.3.1. Company overview
    • 7.3.2. Key executives
    • 7.3.3. Company snapshot
    • 7.3.4. Operating business segments
    • 7.3.5. Product portfolio
    • 7.3.6. Business performance
    • 7.3.7. Key strategic moves and developments
  • 7.4. Artivion, Inc.
    • 7.4.1. Company overview
    • 7.4.2. Key executives
    • 7.4.3. Company snapshot
    • 7.4.4. Operating business segments
    • 7.4.5. Product portfolio
    • 7.4.6. Business performance
    • 7.4.7. Key strategic moves and developments
  • 7.5. Boston Scientific Corporation
    • 7.5.1. Company overview
    • 7.5.2. Key executives
    • 7.5.3. Company snapshot
    • 7.5.4. Operating business segments
    • 7.5.5. Product portfolio
    • 7.5.6. Business performance
    • 7.5.7. Key strategic moves and developments
  • 7.6. LivaNova PLC
    • 7.6.1. Company overview
    • 7.6.2. Key executives
    • 7.6.3. Company snapshot
    • 7.6.4. Operating business segments
    • 7.6.5. Product portfolio
    • 7.6.6. Business performance
    • 7.6.7. Key strategic moves and developments
  • 7.7. Edwards Lifesciences Corporation
    • 7.7.1. Company overview
    • 7.7.2. Key executives
    • 7.7.3. Company snapshot
    • 7.7.4. Operating business segments
    • 7.7.5. Product portfolio
    • 7.7.6. Business performance
    • 7.7.7. Key strategic moves and developments
  • 7.8. ShockWave Medical, Inc.
    • 7.8.1. Company overview
    • 7.8.2. Key executives
    • 7.8.3. Company snapshot
    • 7.8.4. Operating business segments
    • 7.8.5. Product portfolio
    • 7.8.6. Business performance
    • 7.8.7. Key strategic moves and developments
  • 7.9. Medtronic plc
    • 7.9.1. Company overview
    • 7.9.2. Key executives
    • 7.9.3. Company snapshot
    • 7.9.4. Operating business segments
    • 7.9.5. Product portfolio
    • 7.9.6. Business performance
    • 7.9.7. Key strategic moves and developments
  • 7.10. JenaValve Technology, Inc.
    • 7.10.1. Company overview
    • 7.10.2. Key executives
    • 7.10.3. Company snapshot
    • 7.10.4. Operating business segments
    • 7.10.5. Product portfolio
    • 7.10.6. Business performance
    • 7.10.7. Key strategic moves and developments